Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1987 1
1990 2
1991 4
1992 5
1993 1
1994 1
1995 7
1996 7
1997 2
1998 3
1999 5
2000 2
2001 4
2002 9
2003 6
2004 6
2005 13
2006 5
2007 5
2008 7
2009 14
2010 10
2011 10
2012 20
2013 25
2014 18
2015 29
2016 18
2017 24
2018 31
2019 29
2020 22
2021 23
2022 21
2023 15
2024 17

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

377 results

Results by year

Filters applied: . Clear all
Page 1
European guidelines on microscopic colitis: United European Gastroenterology and European Microscopic Colitis Group statements and recommendations.
Miehlke S, Guagnozzi D, Zabana Y, Tontini GE, Kanstrup Fiehn AM, Wildt S, Bohr J, Bonderup O, Bouma G, D'Amato M, Heiberg Engel PJ, Fernandez-Banares F, Macaigne G, Hjortswang H, Hultgren-Hörnquist E, Koulaouzidis A, Kupcinskas J, Landolfi S, Latella G, Lucendo A, Lyutakov I, Madisch A, Magro F, Marlicz W, Mihaly E, Munck LK, Ostvik AE, Patai ÁV, Penchev P, Skonieczna-Żydecka K, Verhaegh B, Münch A. Miehlke S, et al. Among authors: bouma g. United European Gastroenterol J. 2021 Feb 22;9(1):13-37. doi: 10.1177/2050640620951905. Online ahead of print. United European Gastroenterol J. 2021. PMID: 33619914 Free PMC article.
Celiac disease: New therapies on the horizon.
Dieckman T, Koning F, Bouma G. Dieckman T, et al. Among authors: bouma g. Curr Opin Pharmacol. 2022 Oct;66:102268. doi: 10.1016/j.coph.2022.102268. Epub 2022 Jul 31. Curr Opin Pharmacol. 2022. PMID: 35921776 Free article. Review.
Ozanimod as Induction and Maintenance Therapy for Ulcerative Colitis.
Sandborn WJ, Feagan BG, D'Haens G, Wolf DC, Jovanovic I, Hanauer SB, Ghosh S, Petersen A, Hua SY, Lee JH, Charles L, Chitkara D, Usiskin K, Colombel JF, Laine L, Danese S; True North Study Group. Sandborn WJ, et al. N Engl J Med. 2021 Sep 30;385(14):1280-1291. doi: 10.1056/NEJMoa2033617. N Engl J Med. 2021. PMID: 34587385 Clinical Trial.
A Randomized Trial of a Transglutaminase 2 Inhibitor for Celiac Disease.
Schuppan D, Mäki M, Lundin KEA, Isola J, Friesing-Sosnik T, Taavela J, Popp A, Koskenpato J, Langhorst J, Hovde Ø, Lähdeaho ML, Fusco S, Schumann M, Török HP, Kupcinskas J, Zopf Y, Lohse AW, Scheinin M, Kull K, Biedermann L, Byrnes V, Stallmach A, Jahnsen J, Zeitz J, Mohrbacher R, Greinwald R; CEC-3 Trial Group. Schuppan D, et al. N Engl J Med. 2021 Jul 1;385(1):35-45. doi: 10.1056/NEJMoa2032441. N Engl J Med. 2021. PMID: 34192430 Free article. Clinical Trial.
Reply.
Dieckman T, Schumann M, Beaumont H, Bontkes H, Koning F, Bouma G; RCDII Tofacitinib Consortium. Dieckman T, et al. Among authors: bouma g. Clin Gastroenterol Hepatol. 2024 Oct 19:S1542-3565(24)00904-2. doi: 10.1016/j.cgh.2024.08.045. Online ahead of print. Clin Gastroenterol Hepatol. 2024. PMID: 39427853 No abstract available.
Microscopic colitis.
Bouma G, Münch A. Bouma G, et al. Dig Dis. 2015;33(2):208-214. doi: 10.1159/000369517. Epub 2015 Apr 22. Dig Dis. 2015. PMID: 25925924 Review.
Auto immune hepatitis.
van Gerven NM, de Boer YS, Mulder CJ, van Nieuwkerk CM, Bouma G. van Gerven NM, et al. Among authors: bouma g. World J Gastroenterol. 2016 May 21;22(19):4651-61. doi: 10.3748/wjg.v22.i19.4651. World J Gastroenterol. 2016. PMID: 27217697 Free PMC article. Review.
Superior Effectiveness of Tofacitinib Compared to Vedolizumab in Anti-TNF-experienced Ulcerative Colitis Patients: A Nationwide Dutch Registry Study.
Straatmijer T, Biemans VBC, Visschedijk M, Hoentjen F, de Vries A, van Bodegraven AA, Bodelier A, de Boer NKH, Dijkstra G, Festen N, Horjus C, Jansen JM, Jharap B, Mares W, van Schaik FDM, Ponsioen C, Romkens T, Srivastava N, van der Voorn MMPJA, West R, van der Woude J, Wolvers MDJ, Pierik M, van der Meulen-de Jong AE, Duijvestein M; Initiative on Crohn and Colitis. Straatmijer T, et al. Clin Gastroenterol Hepatol. 2023 Jan;21(1):182-191.e2. doi: 10.1016/j.cgh.2022.04.038. Epub 2022 May 26. Clin Gastroenterol Hepatol. 2023. PMID: 35644343 Free article.
Reply.
van Gils T, Rootsaert B, Bouma G, Mulder CJ. van Gils T, et al. Among authors: bouma g. J Gastrointestin Liver Dis. 2017 Mar;26(1):93. doi: 10.15403/jgld.2014.1121.261.gil. J Gastrointestin Liver Dis. 2017. PMID: 28338121 Free article. No abstract available.
Incidence and predictors of hepatocellular carcinoma in patients with autoimmune hepatitis.
Colapietro F, Maisonneuve P, Lytvyak E, Beuers U, Verdonk RC, van der Meer AJ, van Hoek B, Kuiken SD, Brouwer JT, Muratori P, Aghemo A, Carella F, van den Berg AP, Zachou K, Dalekos GN, Di Zeo-Sánchez DE, Robles M, Andrade RJ, Montano-Loza AJ, van den Brand FF, Slooter CD, Macedo G, Liberal R, de Boer YS, Lleo A; Dutch AIH Study Group; International Autoimmune Hepatitis Group. Colapietro F, et al. J Hepatol. 2024 Jan;80(1):53-61. doi: 10.1016/j.jhep.2023.09.010. Epub 2023 Oct 5. J Hepatol. 2024. PMID: 37802188
377 results